logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZTO EXPRESS-W (02057) spent $4.9955 million to repurchase 226,700 shares on June 9th.

date
12:12 10/06/2026
avatar
GMT Eight
Zhongtong Express-W (02057) announced that on June 9, 2026, the company will spend $4,995,500 to repurchase 226,700 shares at a repurchase price of $21.88-22.36 per share.
ZTO EXPRESS-W (02057) announced that on June 9, 2026, the company will spend 4.9955 million US dollars to repurchase 226,700 shares at a repurchase price of $21.88-22.36 per share.
Related Articles
HK Stock Market Move | MOBVISTA (01860) rose nearly 5%, with the company's revenue showing steady year-on-year growth. The IAP ROAS model is expected to accelerate.
HK Stock Market Move | Long-acting anti-TSLP antibody phase II clinical trial completes first dosing, HBM HOLDINGS-B(02142) and SKB BIO(06990) both rose more than 5% in intraday trading.
CMSC: First gives MOBVISTA (01860) a "strong recommendation" rating, product iteration drives high performance growth.
HK Stock Market Move | MOBVISTA (01860) rose nearly 5%, with the company's revenue showing steady year-on-year growth. The IAP ROAS model is expected to accelerate.
HK Stock Market Move | Long-acting anti-TSLP antibody phase II clinical trial completes first dosing, HBM HOLDINGS-B(02142) and SKB BIO(06990) both rose more than 5% in intraday trading.
CMSC: First gives MOBVISTA (01860) a "strong recommendation" rating, product iteration drives high performance growth.
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.